Medicine Research Network Launched at UCC
The UCC School of Pharmacy-led PEARRL (Pharmaceutical Education and Research with Regulatory Links) Network officially launched this week. The network, funded by Horizon 2020 and Marie Sklodowska-Curie innovation programme, aims to achieve earlier patient access to new medicines, has been launched.
The PEARRL project brings together 18 leading European institutions, including Pharma industry, academia and regulatory agency partners to deliver a unique research and training programme.
Fifteen early stage researchers will be recruited in PEARRL, to focus on research into developing drug formulation strategies to enable accelerated approval and reduced cost of development, in turn facilitating earlier patient access to breakthrough therapies.
Project Coordinator of PEARRL Dr Brendan Griffin, from the School of Pharmacy, UCC, said: “Within PEARRL, our research will develop novel drug delivery technology, new screening methods and innovative models to forecast drug levels in humans, which will collectively streamline the development of new oral medicines. In addition, PEARRL will provide a unique training network for developing the next generation of leading pharmaceutical and regulatory scientists.”
